Mortality, Severity, and Hospital Admission among COVID-19 Patients with ACEI/ARB Use: A Meta-Analysis Stratifying Countries Based on Response to the First Wave of the Pandemic

Mortality, Severity, and Hospital Admission among COVID-19 Patients with ACEI/ARB Use: A Meta-Analysis Stratifying Countries Based on Response to the First Wave of the Pandemic

Background: The use of angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) is controversial for treating COVID-19 patients. We aimed to estimate pooled risks of mortality, disease severity, and hospitalization associated with ACEI/ARB use and stratify them by cou...

Full description

Bibliographic Details
Main Authors: Ahmad A. Alamer, Abdulaziz S. Almulhim, Ahmed A. Alrashed, Ivo Abraham
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Healthcare
Subjects:
angiotensin-converting enzyme inhibitor
angiotensin II receptor blocker
Covid-19
mortality
disease severity
hospital admission
Online Access:https://www.mdpi.com/2227-9032/9/2/127

Similar Items

Similar Items